1-3 of 3
Thorsten Langer
Close
Sort by
Journal Articles

Germline genetic variations in methotrexate candidate genes are associated with pharmacokinetics, toxicity, and outcome in childhood acute lymphoblastic leukemia

Clinical Trials & Observations
Susanne Radtke, Oliver Zolk, Bertold Renner, Marios Paulides, Martin Zimmermann, Anja Möricke, Martin Stanulla, Martin Schrappe, Thorsten Langer
Journal: Blood
Blood (2013) 121 (26): 5145–5153.
https://doi.org/10.1182/blood-2013-01-480335
Published: 2013
Includes: Supplemental data
Journal Articles

TBI Based Conditioning Regimen and Intra Osseous Application of PBSC to Overcome Graft Resistance In a Patient with Autoimmune Lymphoproliferative Syndrome (ALPS)

Daniel Stachel, MD, Nora Naumann-Bartsch, MD, Patrick Morhart, MD, Markus Metzler, MD, Thorsten Langer, MD, Klaus Schwarz, Wolfgang Holter, MD
Journal: Blood
Blood (2010) 116 (21): 4696.
https://doi.org/10.1182/blood.V116.21.4696.4696
Published: 2010
Journal Articles

Inv(11)(q21q23) Fuses MLL to the NOTCH Co-Activator Mastermind-Like 2 in Secondary T Cell Acute Lymphoblastic Leukemia.

Markus Metzler, Jan Zuna, Martin S. Staege, Lana Harder, Claus Meyer, Thomas Flohr, Joerg Meerpohl, Eva Fronkova, Thorsten Langer, Jochen Harbott, Jan Trka, Reiner Siebert, Rolf Marschalek, Charlotte Marie Niemeyer, Wolfgang Rascher
Journal: Blood
Blood (2006) 108 (11): 4284.
https://doi.org/10.1182/blood.V108.11.4284.4284
Published: 2006